recombinant live-attenuated RSV vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant live-attenuated RSV vaccine, covering 2018-08-27 to 2018-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]